- Home
- ASA vs ABSI Comparison
ASA vs ABSI Comparison
Compare ASA & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASA
- ABSI
- Stock Information
- Founded
- ASA 1958
- ABSI 2011
- Country
- ASA United States
- ABSI United States
- Employees
- ASA N/A
- ABSI N/A
- Industry
- ASA Precious Metals
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- ASA Industrials
- ABSI Health Care
- Exchange
- ASA Nasdaq
- ABSI Nasdaq
- Market Cap
- ASA 393.9M
- ABSI 457.6M
- IPO Year
- ASA N/A
- ABSI 2021
- Fundamental
- Price
- ASA $20.04
- ABSI $2.99
- Analyst Decision
- ASA
- ABSI Strong Buy
- Analyst Count
- ASA 0
- ABSI 6
- Target Price
- ASA N/A
- ABSI $8.67
- AVG Volume (30 Days)
- ASA 54.3K
- ABSI 2.5M
- Earning Date
- ASA 01-27-2025
- ABSI 11-12-2024
- Dividend Yield
- ASA 0.20%
- ABSI N/A
- EPS Growth
- ASA 302.95
- ABSI N/A
- EPS
- ASA 4.56
- ABSI N/A
- Revenue
- ASA $1,993,559.00
- ABSI $4,207,000.00
- Revenue This Year
- ASA N/A
- ABSI $7.12
- Revenue Next Year
- ASA N/A
- ABSI $202.16
- P/E Ratio
- ASA $4.38
- ABSI N/A
- Revenue Growth
- ASA N/A
- ABSI N/A
- 52 Week Low
- ASA $13.18
- ABSI $2.45
- 52 Week High
- ASA $22.78
- ABSI $6.72
- Technical
- Relative Strength Index (RSI)
- ASA 44.99
- ABSI 43.82
- Support Level
- ASA $19.37
- ABSI $2.79
- Resistance Level
- ASA $20.44
- ABSI $4.11
- Average True Range (ATR)
- ASA 0.58
- ABSI 0.43
- MACD
- ASA -0.08
- ABSI -0.02
- Stochastic Oscillator
- ASA 25.97
- ABSI 11.15
About ASA ASA Gold and Precious Metals Limited
ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.